Literature DB >> 2613920

Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?

M Stolte1, S Eidt.   

Abstract

The prevalence of lymphoid follicles in endoscopic biopsy specimens from normal antral mucosa (n = 220), mucosa with reflux gastritis (n = 104), and in cases with Campylobacter pylori-associated gastritis (n = 2544) was studied. In the latter group whether there were associations between degree and activity of gastritis and the prevalence of lymphoid follicles and between the occurrence of lymphoid follicles and the presence of intestinal metaplasia in the antrum were investigated. In cases with normal mucosa and in those with reflux gastritis lymphoid follicles were not detected, but mucosal lymphoid follicles were found in 1297 (54%) of the cases with C pylori-associated gastritis. The prevalence of lymphoid follicles in the antral mucosa depended on the degree and activity of the gastritis and also correlated with the presence of intestinal metaplasia. The development of lymphoid follicles in the mucosa of the antrum probably represents, primarily, an immune response to the colonisation of the mucosa by C pylori.

Entities:  

Mesh:

Year:  1989        PMID: 2613920      PMCID: PMC502053          DOI: 10.1136/jcp.42.12.1269

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  [Campylobacter pylori and gastritis. Association or induction?].

Authors:  M Stolte; S Eidt; M Ritter; B Bethke
Journal:  Pathologe       Date:  1989-01       Impact factor: 1.011

2.  Lymphoid follicles appearing in gastric mucosa, especially in reactive lymphoid hyperplasia and malignant lymphoma.

Authors:  K Takaki
Journal:  Acta Pathol Jpn       Date:  1986-11

Review 3.  [Diffuse lymphatic hyperplasia, lymphoma and pseudolymphoma of the gastrointestinal system].

Authors:  W Rösch; H Fuchs
Journal:  Dtsch Med Wochenschr       Date:  1972-06-02       Impact factor: 0.628

4.  [Campylobacter pylori and gastritis--the density of colonization and degree of inflammation. A semiquantitative and morphometric study].

Authors:  H Steininger; U Schneider; K Bartz; B Simmler
Journal:  Leber Magen Darm       Date:  1989-03

5.  Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue.

Authors:  P Isaacson; D H Wright
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

6.  Lymphoid hyperplasia of the gastrointestinal tract. A study of 26 cases and review of the literature.

Authors:  M Ranchod; K J Lewin; R F Dorfman
Journal:  Am J Surg Pathol       Date:  1978-12       Impact factor: 6.394

7.  Pseudolymphoma of the stomach. A clinicopathologic study of 15 cases.

Authors:  O Tokunaga; T Watanabe; M Morimatsu
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

8.  Primary gastric lymphoma--a tumour of mucosa-associated lymphoid tissue. A histological and immunohistochemical study of 36 cases.

Authors:  I Moore; D H Wright
Journal:  Histopathology       Date:  1984-11       Impact factor: 5.087

9.  Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review.

Authors:  J J Brooks; H T Enterline
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

10.  Reflux gastritis: distinct histopathological entity?

Authors:  M F Dixon; H J O'Connor; A T Axon; R F King; D Johnston
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

  10 in total
  49 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Primary gastric T-cell lymphoma accompanied by HTLV-I, HBV and H. pylori infection.

Authors:  T Itatsu; H Miwa; R Ohkura; R Iwazaki; H Oide; T Murai; M Nakajima; S Watanabe; S Hirai; M Otaka; N Sato
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Blood groups Lewis(b) and ABH expression in gastric mucosa: lack of inter-relation with Helicobacter pylori colonisation and occurrence of gastric MALT lymphoma.

Authors:  G Oberhuber; A Kranz; C Dejaco; B Dragosics; I Mosberger; W Mayr; T Radaszkiewicz
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

4.  Interleukin-10 (-819 C/T) and TNF-A (-308 G/A) as risk factors for H. pylori-associated gastric MALT-lymphoma.

Authors:  Stephan Hellmig; Tobias Bartscht; Wolfgang Fischbach; Ulrich Robert Fölsch; Stefan Schreiber
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

5.  Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.

Authors:  S K Banerjee; A P Weston; M N Zoubine; D R Campbell; R Cherian
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.

Authors:  Chuan Zhang; Nobutaka Yamada; Yun-Lin Wu; Min Wen; Takeshi Matsuhisa; Norio Matsukura
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

7.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.

Authors:  W Fischbach; M-E Goebeler-Kolve; B Dragosics; A Greiner; M Stolte
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 8.  A Bacterial Cause of Cancer: An Historical Essay.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2017-04-21

9.  The prevalence of lymphoid follicles in Helicobacter pylori associated gastritis in patients with ulcers and non-ulcer dyspepsia.

Authors:  A M Zaitoun
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

10.  Immune suppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells.

Authors:  U Knipp; S Birkholz; W Kaup; W Opferkuch
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.